Hundreds of protesters took to the streets of Hollywood outside the CNN headquarters on Sunday afternoon to voice their frustration with the lack of coverage of Democratic presidential candidate Bernie Sanders.
Protesters used the hashtags #OccupyCNN and #BernieBlackout to organize and speak out against the unequal time given to covering Republican presidential candidate Donald Trump over Sanders. Last Saturday, Sanders won the Hawaii, Washington and Alaska primaries by large numbers but the network barely covered the news, activists say downplaying the victories. This while giving a disproportionate amount of time to covering Donald Trump’s latest antics.
“Stop showing Trump so much,” said a man interviewed by Periscope user @SandersFangirl. “Stick to the issues.”
“There should be fair and equal coverage for all presidential candidates,” said a man also interviewed by @SandersFangirl.
Other Sanders fans have alleged CNN has lost its objectivity because Sanders’ Democratic opponent Hillary Clinton has garnered significant sums from employees of Time Warner, CNN’s parent company.
As of Sunday afternoon CNN had not released a statement on the incident.
— Anna Le Claire (@annaleclaire) April 3, 2016
Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report
According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.
The report, by the Times' Reid Epstein, begins with one such possible scenario.
‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint
Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.
Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity
Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.
Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.